PMID 33507118
Why Functional Medicine Practitioners Test IGFBP-3 In a therapeutic landscape where growth signaling must be both effective and regulated, IGFBP-3 offers deeper insight than IGF-1 alone
In addition to helping patients with type 2 diabetes control their blood sugar, tirzepatide recently received positive results in a Phase 3 clinical trial for the treatment of generally obese individuals who do not have type 2 diabetes
Central nervous system GLP-1 receptors are distributed throughout brain regions implicated in depression, including the hippocampus, prefrontal cortex, and nucleus accumbens
N-acetylcysteine (NAC), a GSH precursor that crosses the blood-brain barrier, has shown promise in preliminary studies and warrants further investigation as a preventive treatment [47, 48]
This prescription-strength B12 injection is typically used as a maintenance therapy and is often dosed at 1 mL once a month